Opinion: Research, Restricted

Are the international drug laws the worst impediment to scientific inquiry since the Catholic Church banned the telescope?

Written byDavid Nutt
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

FLICKR, L'ORSO SUL MONOCICLOOver the centuries there have been many attempts by various governments and other regulatory bodies to limit research on areas that challenge their beliefs and preconceptions. A recent example is the restrictions placed on embryonic stem cell research in the United States and elsewhere. The stranglehold these regulations put on research in these countries drove many US “stars” to the United Kingdom, where less draconian existed. Recognizing this loss, President Obama and others have fought against these restrictions, with some success. But there are other areas of research that continue to be thwarted by overbearing regulations put forth by closed-minded politicians.

In my 45 years in science, for example, there has been a worldwide ban on the study of psychedelics and other drugs. I would contend has been the most extreme form of scientific censorship since the Catholic Church banned the telescope when in the 17th century because Galileo used it to confirm Copernicus’s theory that the earth circled the sun, not the other way around. Galileo was threatened with death for challenging the teaching of the scriptures, and he eventually retracted his claims. Some of his inquisitors refused even to look down a telescope believing it to be the work of the devil.

The current case of scientific censorship derives from the 1961 and 1971 United Nations conventions on narcotic and psychotropic drugs. These conventions ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies